JCI Insight is a Gold Open Access journal in which all content is freely available without charge to the user or their institution. Authors retain copyright to their work, which is published with a Creative Commons Attribution License (CC BY 4.0). Users of the articles are allowed to read, download, copy, distribute, print, search, and link to the full texts of the articles, and use them for any other lawful purpose, without asking prior permission from the publisher or the author. The ASCI retains copyright to many articles published prior to August 20, 2020; while such articles are freely available, permission may be required for re-use; see License Information for details.
JCI Insight deposits published research articles in PubMed Central, which satisfies the NIH Public Access Policy and other similar funding agency requirements.
The Journal meets cOAlition S requirements for authors who receive funding support from Plan S signatories and is fully compliant with the Howard Hughes Medical Institute (HHMI), Wellcome, and UK Research and Innovation (UKRI) open access policies; and is indexed in Securing a Hybrid Environment for Research Preservation and Access (Sherpa Romeo) and included in the Directory of Open Access Journals (DOAJ).
JCI Insight is owned and self-published by the American Society for Clinical Investigation, based in Ann Arbor, Michigan. In order to support the costs of open access publication, authors of accepted JCI Insight research articles are assessed a publication fee of $4,100. This fee supports the following expenses:
Requests for publication fee discounts are considered on a case-by-case basis.